AKT1 gene polymorphisms and obstetric complications in the patients with schizophrenia

Psychiatry Investigation

Volumn 6, Issue 2, 2009, Pages 102-107

  Joo, Eun Jeong ^a   Lee, Kyu Young ^a   Jeong, Seong Hoon ^b   Roh, Myoung Sun ^c   Se, Hyun Kim ^c   Ahn, Yong Min ^c   Yong, Sik Kim ^c  

^a Eulji University School of Medicine   (South Korea)

^b Dongguk University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

AKT1 gene; Association; Lewis scale; Obstetric complication; Schizophrenia

Indexed keywords

PROTEIN KINASE B;

ADULT; ALLELE; ARTICLE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERINATAL PERIOD; PREGNANCY COMPLICATION; PRENATAL PERIOD; RATING SCALE; RETROSPECTIVE STUDY; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; V AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 1 GENE;

EID: 67651151472     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: 10.4306/pi.2009.6.2.102     Document Type: Article

References (33)

1. O'Callaghan E, Gibson T, Colohan HA, Buckley P, Walshe DG, Larkin C, et al. Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study. BMJ 1992;305:1256-1259.
2. Preti A, Cardascia L, Zen T, Marchetti M, Favaretto G, Miotto P. Risk for obstetric complications and schizophrenia. Psychiatry Res 2000;96:127-139.
3. Cannon M, Jones PB, Murray RM. Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry 2002;159:1080-1092. (Pubitemid 34743246)
4. Cannon TD, Rosso IM, Hollister JM, Bearden CE, Sanchez LE, Hadley T. A prospective cohort study of genetic and perinatal influences in the etiology of schizophrenia. Schizophr Bull 2000;26:351-366.
5. Schmidt-Kastner R, van Os J, W M Steinbusch H, Schmitz C. Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia. Schizophr Res 2006;84:253-271.
6. Kietzmann T, Knabe W, Schmidt-Kastner R. Hypoxia and hypoxia-inducible factor modulated gene expression in brain: involvement in neuroprotection and cell death. Eur Arch Psychiatry Clin Neurosci 2001;251:170-178. (Pubitemid 32963494)
7. Nicodmus KK, Marenco S, Batten AJ, Vakkalanka R, Egan MF, Straub RE, et al. Serious obstetric complications interact with hypoxia-regulated/vascular- expression genes to influence schizophrenia risk. Mol Psychiatry 2008;13:873-877.
8. Brazil DP, Yang ZZ, Hemmings BA. Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem Sci 2004;29:233-242.
9. Janelidze S, Hu BR, Siesjö P, Siesjö BK. Alterations of Akt1 (PKBalpha) and p70 (S6K) in transient focal ischemia. Neurobiol Dis 2001;8:147-154.
10. Li L, Qu Y, Mao M, Xiong Y, Mu D. The involvement of phosphoinositid 3-kinase/Akt pathway in the activation of hypoxia-inducible factor-1 alpha in the developing rat brain after hypoxia-ischemia. Brain Res 2008;1197:152-158.
11. Noshita N, Lewén A, Sugawara T, Chan PH. Evidence of phosphorylation of Akt and neuronal survival after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2001;21:1442-1450. (Pubitemid 33120944)
12. Shibata M, Yamawaki T, Sasaki T, Hattori H, Hamada J, Fukuuchi Y, et al. Upregulation of Akt phosphorylation at the early stage of middle cerebral artery occlusion in mice. Brain Res 2002;942:1-10. (Pubitemid 34597063)
13. Yin XH, Zhang QG, Miao B, Zhang GY. Neuroprotective effects of preconditioning ischemia on ischemic brain injury through inhibition of mixed-lineage kinase 3 via NMDA receptor-mediated Akt1 activation. J Neurochem 2005;93:1021-1029. (Pubitemid 40695761)
14. Zhang W, Wang R, Han SF, Bu L, Wang SW, Ma H, et al. Alpha-linolenic acid attenuates high glucose-induced apoptosis in cultured human umbilical vein endothelial cells via PI3K/Akt/eNOS pathway. Nutrition 2007;23:762-770. (Pubitemid 47409966)
15. Ahn YM, Seo MS, Kim SH, Kim Y, Yoon SC, Juhnn YS, et al. Increased phosphorylation of Ser473-Akt, Ser9-GSK-3beta and Ser133-CREB in the rat frontal cortex after MK-801 intraperitoneal injection. Int J Neuropsychopharmacol 2005;8:607-613. (Pubitemid 41400892)
16. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 2004;36:131-137.
17. Thiselton DL, Vladimirov VI, Kuo PH, McClay J, Wormley B, Fanous A, et al. AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high-density schizophrenia families. Biol Psychiatry 2008;63:449-457.
18. Kalkman HO. The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia. Pharmacol Ther 2006;110:117-134. (Pubitemid 43248729)
19. Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, et al. Association of AKT1 with schizophrenia confirmed in a Japanese population. Biol Psychiatry 2004;56:698-700. (Pubitemid 39446853)
20. Schwab SG, Hoefgen B, Hanses C, Hassenbach MB, Albus M, Lerer B, et al. Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol Psychiatry 2005;58:446450. (Pubitemid 41393606)
21. Xu MQ, Xing QH, Zheng YL, Li S, Gao JJ, He G, et al. Association of AKT1 gene polymorphisms with risk of schizophrenia and with response to antipsychotics in the Chinese population. J Clin Psychiatry 2007;68:1358-1367. (Pubitemid 47524515)
22. Joo EJ, Joo YH, Hong JP, Hwang S, Maeng SJ, Han JH, et al. Korean version of the diagnostic interview for genetic studies: validity and reliability. Compr Psychiatry 2004;45:225-229. (Pubitemid 38656680)
23. Lewis SW, Murray RM. Obstetric complications, neurodevelopmental deviance and risk of schizophrenia. J Psychiatr Res 1987;21:413-421. (Pubitemid 18010253)
24. Lewontin RC. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 1964;49:49-67.
25. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 2008;66:87-98.
26. Nelson MD, Saykin AJ, Flashman LA, Riordan HJ. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry 1998;55:433-440.
27. Rehn AE, Van Den Buuse M, Copolov D, Briscoe T, Lambert G, Rees S. An animal model of chronic placental insufficiency: relevance to neurodevelopmental disorders including schizophrenia. Neuroscience 2004;129:381-391. (Pubitemid 39388857)
28. Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr Res 2001;49:1-52.
29. Carmeliet P. Blood vessels and nerves: common signals, pathways and diseases. Nat Rev Genet 2003;4:710-720. (Pubitemid 37046138)
30. Zhu C, Xu F, Wang X, Shibata M, Uchiyama Y, Blomgren K, et al. Different apoptotic mechanisms are activated in male and female brains after neonatal hypoxia-ischaemia. J Neurochem 2006;96:1016-1027.
31. Buka SL, Goldstein JM, Spartos E, Tsuang MT. The retrospective measurement of prenatal and perinatal events: accuracy of maternal recall. Schizophr Res 2004;71:417-426. (Pubitemid 39330520)
32. Sou SC, Chen WJ, Hsieh WS, Jeng SF. Severe obstetric complications and birth characteristics in preterm or term delivery were accurately recalled by mothers. J Clin Epidemiol 2006;59:429435.
33. Van Os J, Marcelis M. The ecogenetics of schizophrenia: a review. Schizophr Res 1998;32:127-135.